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Abstract We investigated the mechanisms underlying the pro-
apoptotic activity exerted by oxidized low-density lipoproteins
(oxLDL) in Caco-2 intestinal cells, a cell line which retains
many morphological and enzymatic features typical of normal
human enterocytes. We found that: (i) oxLDL induced mito-
chondrial-mediated apoptosis by provoking ¢rst an increase in
mitochondrial membrane potential, followed, later, by the typi-
cal apoptosis-associated depolarization (type II apoptosis) ; ac-
cordingly, (ii) caspase-9 inhibition signi¢cantly hindered apopto-
sis while caspase-8 inhibition did not; and ¢nally (iii) dietary
phenolic antioxidizing compounds exerted a signi¢cant protec-
tive antiapoptotic activity. These results point to mitochondrial
hyperpolarization as ‘sensitizing feature’ in apoptotic proneness
of Caco-2 intestinal cells to oxLDL exposure. - 2002 Feder-
ation of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
Key words: Caco-2; Mitochondrial membrane potential ;
Apoptotic pathway; oxLDL
1. Introduction
The complex cascade of events involving pro-apoptotic or
antiapoptotic signals depend upon, or are associated with, the
type of the ‘trigger’ that activates the process [1]. A hypothesis
regarding two di¡erent cell types characterized by di¡erent
apoptotic pathways has in fact been proposed. These two
cell pathways are referred to di¡erent initiation patterns [2].
In particular, caspase-9-driven apoptotic machinery seems to
mainly involve mitochondrial-associated caspase cascade,
while caspase-8-mediated apoptosis appears to be of impor-
tance in the receptor-mediated, i.e. Fas-mediated, cell death
[2].
Dysregulated apoptosis is actually found in a number of
pathologic conditions of the gastrointestinal tract [3,4]. Being
the interface between the organism and its luminal environ-
ment, the intestine is in fact constantly challenged by diet-
derived oxidants as well as by endogenously generated reac-
tive oxygen species (ROS) or oxidants. In particular, a high
intake of dietary polyunsaturated fatty acids can contribute to
the luminal accumulation of lipid hydroperoxides and, subse-
quently, lipid peroxidation products that can induce oxidative
stress and redox imbalance [5,6]. In the same vein, low-density
lipoproteins undergoing oxidative modi¢cation (oxLDL), gen-
erate a mixture of compounds with cytotoxic activity, such as
products of lipid peroxidation (4-hydroxy-2,3-nonenal, lipid
hydroperoxides and oxysterols). In turn, the interaction of
oxLDL-derived oxidizing products with cells and tissues re-
sults in oxidative imbalance leading to cell death by apoptosis
[7,8]. Oxidative stress has been associated with many forms of
programmed cell death and there is strong evidence that ROS
can induce the apoptotic process. On the other hand, it is
generally accepted that antioxidizing drugs can prevent apo-
ptosis [9]. Increased attention has been recently devoted to
phenolic compounds, antioxidants that occur naturally in veg-
etables, fruits and beverages [10,11] such as tea, red wine and
extra virgin olive oil, because of their possible bene¢cial role
in the prevention of several oxidative stress-associated dis-
eases, which are characterized by in£ammatory injuries, in-
cluding injury of intestine [12].
Aim of the present work was to investigate the mechanisms
underlying oxLDL-induced apoptosis in Caco-2 cells which,
retaining many of the morphological and enzymatic features
typical of normal human enterocytes [13], are largely used as a
model system for evaluating the e¡ects of normal dietary con-
stituents as well as additives, contaminants, toxicants, oxi-
dants and drugs [12,14,15].
2. Materials and methods
2.1. LDL isolation and oxidation
LDL (1.019^1.063 g/ml) were prepared from freshly isolated pooled
plasma from di¡erent healthy human donors by density gradient ul-
tracentrifugation and than oxidized with 25 WM CuSO4 for 18 h at
37‡C as previously reported [10]. The extent of lipid peroxidation was
estimated as malondialdehyde and 4-hydroxyalkenals content by a
colorimetric kit (LPO 586, Bioxytech S.A., Bonneuil sur Marne,
France). The results showed a mean value of 50.0G 8.2 nmol/mg
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LDL protein in oxidized samples versus 4G 0.05 nmol/mg protein in
native LDL. Modi¢cation of LDL was tested by measuring the in-
crease in electrophoretic mobility on 0.5% agarose gel, and the frag-
mentation of apo B by sodium dodecyl sulfate^polyacrylamide gel
electrophoresis (SDS^PAGE).
2.2. Cell cultures
The human colon cell line Caco-2 was obtained from the European
Collection of Cell Culture (Salisbury, UK). Cells were grown in Dul-
becco’s modi¢ed Eagle’s medium (DMEM, Hyclone, Cramlington,
UK) with 4.5 g glucose per l, supplemented with 1% (v/v) non-essen-
tial amino acids (Flow Laboratories, Irvine, UK), 0.2 mM L-gluta-
mine (Flow), 50 U/ml penicillin (Flow), 50 Wg/ml streptomycin (Flow),
and 10% (v/v) fetal calf serum (Flow), at 37‡C in a humidi¢ed atmo-
sphere of 5% CO2 in air.
2.3. Cell treatments
LDL : native LDL or oxLDL were sterilized by ¢ltration through a
0.2 Wm Millipore membrane (Millipore Corporation, Bedford, MA,
USA) and added after 5 days culture at a ¢nal concentration of
0.2 mg/ml as previously reported [10] for 6, 12, 18, 24 and 48 h.
The same LDL preparations at the same concentration, without ex-
posure to copper, were used as native LDL. Fas : cell cultures were
incubated with (i) 15 ng/ml anti-Fas activating antibody (clone
CH11); (ii) 1 Wg/ml anti-Fas inhibiting antibody (clone ZB4) (Upstate
Biotechnology, Lake Placid, NY, USA) 2 h before exposure to
oxLDL; (iii) 2 Wg/ml anti-FasL inhibiting antibody (clone NOK-1)
(Pharmingen, San Diego, CA, USA) 2 h before exposure to oxLDL.
As further control, mouse IgM (control for Fas triggering), mouse
IgG1 (control for Fas and for FasL neutralizing) were also considered.
Phenols : tyrosol (0.5 mM) and protocatechuic acid (0.25 mM) were
administered in the sterile medium 2 h before exposure to oxLDL and
maintained in the culture medium during treatments. Caspase inhib-
itors : 2 h before the apoptotic stimuli described above, 100 WM Asp-
Glu-Val-Asp-aldehyde (DEVD-CHO) (cell permeant caspase-3 inhib-
itor), LEHD-CHO (cell permeant caspase-9 inhibitor), or Ile-Glu-Thr-
Asp-aldehyde (IETD-CHO) (cell permeant caspase-8 inhibitor) (Bio-
source International, Camarillo, CA, USA) were directly added to the
culture medium. Cells treated with caspase inhibitors alone were con-
sidered as controls. Carbonyl-cyanide p-(tri£uoro-methoxy) phenylhy-
drazone (FCCP): at the same time of oxLDL administration, 40 nM
of FCCP, an uncoupler of mitochondrial oxidation and phosphory-
lation, was added to the culture medium. Cells treated with oxLDL
alone or FCCP alone were considered as control of this series of
experiments.
2.4. Proliferating activity
Cells were exposed to LDL or oxLDL 5 days after seeding in the
presence or absence of tyrosol or protocatechuic acid. After the in-
cubation period, 1.85 kBq of [14C]thymidine (Amersham, Bucking-
hamshire, UK; special activity: 2.09 GBq/mmol) were added to
each well. After a 4-h [14C]thymidine incubation, cells were prepared
as previously reported [10]. Radioactivity was evaluated in 0.2-ml
aliquots of NaOH extracts with a liquid scintillation spectrometer.
[14C]thymidine incorporation was expressed as a percentage of values
observed in untreated cells.
2.5. Apoptosis evaluation
Apoptosis was evaluated with the ApoAlert Annexin V apoptosis
kit (Clontech Laboratories, Palo Alto, CA, USA) following the man-
ufacturer’s instructions. Two-color cytometric analysis (£uorescence-
activated cell sorting (FACS)) was performed on a Coulter Epics Elite
ESP cell Sorter (Miami, FL, USA) with an argon-ion laser tuned at
488 nm.
2.6. Measurement of caspase-3 activity
Activity of caspase-3 was measured by a commercial kit Apo-
AlertTM (Clontech Laboratories, Palo Alto, CA, USA). The assay
is based on spectrophotometric detection of the chromophore p-nitro-
anilide (p-NA) after cleavage from the labeled substrates. The p-NA
light emission can be quanti¢ed using a microtiter plate reader at 405
nm (Novopath, Bio-Rad, Hercules, CA, USA). The fold increase in
caspase activity was determined by comparing the absorbance of
p-NA from apoptosis-induced samples vs. uninduced control samples
[16].
2.7. Intracellular redox state
Control and treated cells (5U105) were harvested and incubated
in 495 Wl of Hanks’ balanced salt solution (HBSS, pH 7.4) with 5 Wl
of hydroetidine (HE, Molecular Probes) or dihydrorhodamine 123
(DHR 123, Molecular Probes) in polypropylene test tubes for
15 min at 37‡C. The ¢nal concentration of HE and DHR 123 were
1 WM and 10 WM, respectively. HE is a non-£uorescent membrane-
permeable ethidium derivative that can be oxidized directly to the red
£uorescent ethidium bromide (EB) by O32 generated inside the cells
Fig. 1. Cytostatic activity and pro-apoptotic e¡ects of oxLDL in in-
testinal cells. A: Relative incorporation of [14C]thymidine by Caco-2
cells exposed to native LDL or oxLDL (0.2 mg/ml) in the presence
or absence of phenolic compounds, 0.5 mM tyrosol (TYR) or 0.25
mM protocatechuic acid (PROT). Each column represents the rela-
tive incorporation after 24 and 48 h treatment as compared with
control values (100%). The data are expressed as meanGS.E.M. of
four independent experiments. *P6 0.001: oxLDL vs. LDL; oxLDL
vs. TYR+oxLDL; oxLDL vs. PROT+oxLDL. B: Percentage of ap-
optotic annexin-V positive cells in control cells (CTR), native LDL
exposed cells (LDL), oxLDL-treated cells (oxLDL) and oxLDL-
treated cells preincubated with tyrosol (TYR+oxLDL) or protocate-
chuic acid (PROT+oxLDL). Values are expressed as meanGS.E.M.
of six independent experiments. *P6 0.001: oxLDL vs. LDL;
oxLDL vs. TYR+oxLDL; oxLDL vs. PROT+oxLDL. C: Quanti¢-
cation of apoptosis in Caco-2 cells incubated with (i) anti-Fas
activating antibody (clone CH11); (ii) anti-Fas activating anti-
body (clone CH11)+anti-Fas inhibiting antibody (clone ZB4); (iii)
anti-FasL inhibiting antibody (clone NOK-1) 2 h before oxLDL
exposure; (iv) anti-Fas inhibiting antibody (clone ZB4) 2 h before
oxLDL exposure; (v) anti-Fas activating antibody (clone CH11)+
tyrosol; (vi) anti-Fas activating antibody (clone CH11)+protoca-
techuic acid. The percentages of annexin-V positive cells 24 h after
apoptotic triggering are reported as meanGS.E.M. of four indepen-
dent experiments. *P6 0.001: anti-Fas activating antibody (clone
CH11)+anti-Fas inhibiting antibody (clone ZB4) vs. anti-Fas acti-
vating antibody (clone CH11).
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after di¡erent treatments. DHR 123 is a dye freely di¡using into cells
which is oxidized primarily by H2O2 in a myeloperoxidase-dependent
reaction to green £uorescence. As these probes can be accumulated by
mitochondria as a function of their membrane potential, we excluded
a possible interference of the di¡erent mitochondrial membrane
potential state showed by variously treated cells with ROS evalua-
tion by using FCCP (20 WM, Sigma) a protonophore that, at this
dose, completely depolarized the mitochondrial membrane, as pre-
viously described [17]. Intracellular GSH content was assessed by
using 10 WM 5-chloromethyl-2P,7P-dichloro-dihydro£uoresceindiace-
tate (CM-H2DCFDA, Molecular Probes). Cells exposed to L-buthio-
nine-[S,R]-sulfoximine 7.5 mM (BSO, Sigma), a GSH depleting drug,
for 16 h were considered as negative controls [17].
2.8. Mitochondrial membrane potential (v8) and mitochondrial mass
The v8 of control and treated cells was studied by using: (i) the
5,5P,6,6P-tetrachloro-1,1P,3,3Ptetraethylbenzimidazolcarbocyanineio-
dide (JC-1) probe (5 WM, Molecular Probes) [18], (ii) the 3,3P-dihex-
yloxacarbocyanine iodide (DiOC6, 500 nM, Molecular Probes), and
(iii) the tetramethylrhodamine ester (TMRM, 1 WM, Molecular
Probes). In consideration of the not signi¢cant di¡erences obtained
with these probes, only results obtained with JC-1 will be shown. As
negative and positive methodological controls, cells were also incuba-
ted for 15 min with 5 mM oligomycin (which induces hyperpolariza-
tion of mitochondria) or with 10 mM valinomycin (which induces
depolarization of mitochondria), respectively. For the analysis of
the mitochondrial mass, cells were incubated at 37‡C for 30 min
with 5 WM nonylacridine orange (NAO, Molecular Probes). Samples
were immediately analyzed by a Becton-Dickinson £ow cytometer.
2.9. Statistical analysis
All data reported are the arithmetic mean from four independent
experiments performed in triplicate G S.E.M. Statistical calculations
were performed using a one-way ANOVA. Di¡erences among groups
were examined using Bonferroni’s t-test. Only P values 6 0.01 were
considered as signi¢cant.
3. Results
3.1. Cytostatic activity and pro-apoptotic e¡ects of oxLDL in
intestinal cells
We ¢rst evaluated subcellular activity of oxLDL by study-
ing their e¡ects on cell proliferation. We found (Fig. 1A) that
native LDL did not induce signi¢cant changes in intestinal cell
proliferation while oxLDL (0.2 mg/ml) induced a signi¢cant
cytostatic e¡ect, which was already evident after 24 h
(60.6 G 7%), and quite strong after 48 h (22.9 G 8%). This
Fig. 2. OxLDL induce redox imbalance in intestinal cells. Cyto-
£uorimetric analysis of (A) superoxide anion production, (B) hydro-
gen peroxide production and (C) intracellular reduced glutathione
after 6, 12, 24 and 48 h exposure to LDL and oxLDL, with or
without the presence of tyrosol (TYR+oxLDL) or protocatechuic
acid (PROT+oxLDL). Values reported represent the mean (from
four independent experiments) G S.E.M. of the median values of the
£uorescence intensity histograms after conversion of logarithmically
ampli¢ed signals into values on a linear scale. Values obtained in
treated cells were compared with values of control untreated cells
(considered as 100%). *P6 0.001: oxLDL vs. LDL; oxLDL vs.
TYR+oxLDL; oxLDL vs. PROT+oxLDL for each parameter and
time considered.
Fig. 3. OxLDL-induced apoptosis is mediated by caspase- 9 and -3.
A: Activity of caspase-3 in oxLDL-treated cells. Reported values
were obtained by considering the di¡erence between caspase-3 activ-
ity found in oxLDL-treated cells and in untreated control cells.
*P6 0.001: 18 h and 24 h oxLDL treatment vs. untreated control
cells. B: Quanti¢cation of oxLDL-induced apoptosis in the absence
and in the presence of DEVD-CHO (caspase-3 inhibitor), LEHD-
CHO (caspase-9 inhibitor), or IETD-CHO (caspase-8 inhibitor).
Values are expressed as meanGS.E.M. of four independent experi-
ments. *P6 0.01: oxLDL vs. DEVD-CHO+oxLDL; oxLDL vs.
LEHD-CHO+oxLDL.
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highly signi¢cant decrease in thymidine uptake (P6 0.001)
was fully counteracted by the two dietary antioxidizing active
drugs tyrosol and protocatechuic acid (Fig. 1A). A time-
course analysis was also performed to evaluate apoptosis.
As reported in Fig. 1B, a signi¢cant increase in the percentage
of apoptotic cells was found after oxLDL administration with
respect to control cells (26G 4% and 40G 6% after oxLDL
exposure for 24 and 48 h, respectively). As for the prolifera-
tion results reported above, no pro-apoptotic activity was ex-
erted by native LDL. OxLDL e¡ects were signi¢cantly coun-
teracted by cell treatment with tyrosol and protocatechuic
acid (Fig. 1B). To evaluate the contribution of the ‘classical’
receptor-mediated cell death pathway in oxLDL-induced ap-
optosis, previously reported for other redox stimuli [19],
Caco-2 cells were incubated with anti-Fas activating antibody.
As controls, anti-Fas neutralizing antibodies or anti-FasL
neutralizing antibodies in the presence or the absence of
oxLDL were analyzed. The data obtained are reported in
Fig. 1C. Unlike other epithelial and intestinal cell lines,
anti-Fas activating antibody triggered apoptosis of Caco-2
cells. When intestinal cells were exposed to oxLDL, the pres-
ence of anti-Fas neutralizing antibody as well as anti-FasL
neutralizing antibody, did not counteract the pro-apoptotic
e¡ects of oxLDL. More importantly, the phenolic compounds
did not exert any protective e¡ect against Fas-triggered apo-
ptosis. These results clearly indicated that (i) Fas/FasL acti-
vation was not involved in oxLDL-induced apoptosis and that
(ii) phenolic drugs exerted their antiapoptotic activity against
mitochondrial-mediated (caspase-9-dependent) apoptosis only,
while were ine¡ective against Fas-mediated cascade (caspase-
8-dependent).
3.2. OxLDL induce redox imbalance in intestinal cells
Considering that cell death by apoptosis can represent the
¢nal event of a redox imbalance, time-course experiments
evaluating the intracellular production of ROS (Fig. 2A and
B), and the GSH content (Fig. 2C) were carried out. Fig. 2A
reports the production of O32 after 6, 18, 24 and 48 h LDL or
oxLDL treatments, in the presence or absence of tyrosol and
protocatechuic acid. The production of intracellular O32 in-
creased early after exposure to oxLDL (6 h) reaching a pla-
teau within 48 h. Treatment with antioxidants fully counter-
acted superoxide anion production, and restored O32 control
values (Fig. 2A). A similar behavior was found upon measur-
Fig. 4. OxLDL induce mitochondrial membrane hyperpolarization. Mitochondrial membrane potential assay obtained by cyto£uorimetric anal-
ysis with JC-1 probe. A: Methodological controls: untreated cells (contour plot on the left), cells treated with oligomycin (hyperpolarized mito-
chondria, contour plot in the middle) and cells treated with valinomycin (depolarized mitochondria, contour plot on the right). B: First col-
umn, untreated control Caco-2 cells (CTR); second column, oxLDL-treated cells (oxLDL); third column, cells treated with tyrosol and oxLDL
(TYR+oxLDL); fourth column, cells treated with protocatechuic acid and oxLDL (PROT+oxLDL). Values in the boxes indicate the percent-
age of cells that express high red £uorescence (corresponding to J-aggregates), which typically increases when the mitochondrial membrane be-
comes hyperpolarized. Percentages in quadrant III are referred to the number of cells with depolarized mitochondria. A representative experi-
ment of four is shown.
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ing hydrogen peroxide production (Fig. 2B). In fact, under the
same experimental conditions, an early signi¢cant increase in
H2O2 production was found 6 h after oxLDL administration.
This e¡ect was fully counteracted by the administration of
phenolic drugs. By contrast, GSH content was signi¢cantly
decreased only 12 h after treatment. The depletion was of
about 50% within 48 h. The presence of the phenolic com-
pounds restored GSH normal values. Notably, powerful ben-
e¢cial e¡ects were mainly exerted by the treatment with pro-
tocatechuic acid, probably due to its chemical structure [20].
3.3. OxLDL-induced apoptosis is mediated by caspase-9 and -3
Two di¡erent apoptotic caspase cascades, i.e. membrane-
associated or mitochondria-associated, have been described.
These involve caspase-8 and -9, respectively [2,21]. Both path-
ways converge to activate downstream events such as caspase-
3 cleavage. Time-course experiments using a spectro£ourimet-
ric method indicated that intestinal cells treated with oxLDL
displayed a caspase-3 activity which was two- and four-fold
higher than in control samples after 18 and 24 h respectively
(Fig. 3A). Moreover, the presence of the speci¢c caspase-3
inhibitor DEVD-CHO (100 WM) reduced apoptosis by about
85% with respect to cells treated with oxLDL alone (Fig. 3B).
The analysis of the e¡ects of caspase-8 and caspase-9 inhib-
itors on oxLDL-induced apoptosis was performed. The results
obtained indicated that LEHD-CHO (caspase-9 inhibitor),
but not IETD-CHO (caspase-8 inhibitor), signi¢cantly
(Ps 0.01) inhibited oxLDL-induced apoptosis (Fig. 3B).
3.4. OxLDL induce mitochondrial membrane hyperpolarization
On the basis of the above results we hypothesize that
oxLDL induced apoptosis in Caco-2 intestinal cells via a di-
rect e¡ect on mitochondria. To verify this hypothesis we an-
alyzed the mitochondrial membrane potential (v8) during
speci¢c time-course experiments by using JC-1. As showed
in Fig. 4A, this probe was able to reveal either an increase
(induced by oligomycin, middle panel) or a decrease (induced
by valinomycin, right panel) of mitochondrial membrane po-
tential. Results reported in Fig. 4B clearly show that an early
peculiar change occurred in oxLDL-treated cells. In fact, a
signi¢cant percentage of oxLDL-treated cells (59G 5%)
showed, as early event, a mitochondrial membrane hyperpo-
larization (Fig. 4B, upper row). This change was followed, as
late event, by the characteristic drop of mitochondrial mem-
brane potential typical of apoptosis (Fig. 4B, middle panels
24 h, bottom panels 48 h). Interestingly, phenolic compounds
were able to inhibit either early (hyperpolarization) or late
(depolarization) oxLDL-induced mitochondrial e¡ects, main-
taining the mitochondrial v8 values similar to those of con-
trol cells. Overlapping results were also obtained by using
alternative probes DiOC6 or TMRM.
3.5. Mitochondrial membrane hyperpolarization is
a prerequisite for oxLDL-induced apoptosis
To explore the possible causal link between mitochondria
hyperpolarization phenomenon and apoptosis in our experi-
mental system, a non-cytotoxic dose (‘baby dose’, 40 nM) of
FCCP, was added to the culture medium at the same time of
oxLDL. This concentration of FCCP did not induce any cy-
totoxic e¡ect (the viability of cells remained s 90%, see Fig.
5B). Interestingly, FCCP was able to prevent either the initial
increase (18 h, left panels of Fig. 5A) or the subsequent de-
cline (48 h, right panels of Fig. 5A) of v8 induced by oxLDL.
More importantly, FCCP also suppressed oxLDL-induced ap-
optosis (Fig. 5B) indicating that the early hyperpolarization of
mitochondrial membrane represents a necessary event for
oxLDL-induced apoptosis. Finally, the same model system
was also employed to better characterize the target e¡ect of
phenolic compounds on mitochondria. In particular, we con-
ducted speci¢c experiments by treating cells with FCCP in the
Fig. 5. Mitochondrial membrane hyperpolarization is a prerequisite
for oxLDL-induced apoptosis. A: Mitochondrial membrane poten-
tial assay obtained by cyto£uorimetric analysis with JC-1 probe.
CTR, untreated control Caco-2 cells ; oxLDL, oxLDL-treated cells ;
FCCP, cells treated with FCCP; FCCP+oxLDL, cells treated with
FCCP and oxLDL at the same time. Values in the boxes indicate
the percentage of cells that express high red £uorescence (corre-
sponding to J-aggregates), which typically increases when the mito-
chondrial membrane becomes hyperpolarized. Percentages in quad-
rant III are referred to the cells with depolarized mitochondria. A
representative experiment of four is shown. B: Percentage of apo-
ptotic annexin-V positive cells in the same samples. Values are ex-
pressed as meanGS.E.M. of three independent experiments. Note
that a signi¢cant di¡erence *P6 0.001 was detectable after 48 h of
oxLDL treatment vs. FCCP given alone or vs. FCCP/oxLDL treat-
ment.
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presence or absence of phenolic compounds (Fig. 6). We
found that: (i) given alone, they did not induce per se mito-
chondrial depolarization typical of the uncouplers (Fig. 6B),
(ii) no additive e¡ects FCCP (baby dose, 40 nM)/phenols were
observed (not shown) and, more importantly, (iii) in the pres-
ence of these agents, the uncoupler activity exerted by FCCP
at a higher concentration (10 WM) was signi¢cantly hindered
(compare Fig. 6C and D, quadrants III and IV). In particular,
the number of cells with depolarized mitochondria after
FCCP administration dropped from 72.0G 3 to 27.1 G 5% in
the presence of protocatechuic acid and down to 28.3G 4% in
the presence of tyrosol. In consideration of the fact that the
results were quite similar, we only show the analytical cytol-
ogy results obtained with protocatechuic acid (Fig. 6).
4. Discussion
Apoptosis was hypothesized to be mediated by two path-
ways that, although strictly intertwined, may represent di¡er-
ent ways to reach the same result, i.e. the death of a cell [2,22].
The ¢rst pathway involves the cells that, via a death receptor
pathway, e.g. by Fas, and upon caspase-8 activation, undergo
apoptotic cascade. This pathway, via bid cleavage, only in-
volves mitochondria later and ¢nally leads to the execution
phase with the cleavage of caspase-3 and poly-ADP-ribose-
polymerase. A second way of caspase activation was shown
to be primarily linked to mitochondrial changes, directly in-
ducing the release of cytochrome c into the cytosol, and ap-
optosome complex formation with activation of caspase-9
[1,23,24]. Importantly, in both apoptotic pathways mitochon-
drial membrane depolarization has been observed [2]. By con-
trast, the earlier event observed in intestinal cells after oxLDL
exposure was the hyperpolarization of mitochondria. This
event, described by other authors for other cell types, i.e.
lymphocytes, seems to represent a prerequisite for rapid mi-
tochondrial-mediated apoptotic cell death that eventually
leads to the loss of mitochondrial membrane potential
[25,26]. This could, at least partially, be related to the oxida-
tive imbalance we found after oxLDL administration in in-
testinal cells. The involvement of ROS species in apoptosis
induced by di¡erent agents, such as oxidants, toxicants or
drugs, was in fact suggested by a number of studies. Moreover
it has been demonstrated that GSH depletion favors oxidative
stress with the induction of apoptosis [27,28]. It can be sup-
posed that GSH depletion is due to active GSH extrusion
from apoptotic cells, or that the cellular oxidized form of
glutathione (GSSG) increased as a consequence of ROS pro-
duction occurring during apoptosis. Consequently, thiol-sup-
plying drugs, e.g. N-acetyl-cysteine, were proved capable of
protecting certain cell types from apoptosis [29]. In the same
vein, our experimental ¢ndings seem to suggest that early
ROS production, GSH depletion and membrane hyperpolari-
zation, can be related events or, conceivably, according to
literature data, the last could be the consequence of the ¢rst
two [30]. Interestingly, phenolic drugs protect from oxLDL
apoptosis and inhibit mitochondrial hyperpolarization. On
the other hand, some literature data also indicated that those
phenolic compounds that are capable of speci¢cally inducing
apoptotic cell death, e.g. resveratrol [31], act via mitochondria
[32]. In any case, mitochondrial homeostasis appears as the
key candidate for the target cytoplasmic activities exerted by
phenolic compounds. According to the above results, apopto-
tic death induced by oxLDL in Caco-2 intestinal polarized
cells was completely antagonized by the presence of the cas-
pase-9 inhibitor LEHD-CHO in the culture medium while
caspase-8 inhibitor IETD-CHO was ine¡ective. In addition,
Fig. 6. FCCP-mediated mitochondrial membrane depolarization is inhibited by protocatechuic acid. Mitochondrial membrane potential assay
obtained by cyto£uorimetric analysis with JC-1 probe. Protocatechuic acid did not induce per se any mitochondrial depolarization in Caco-2
cells (B). By contrast, high concentrations of FCCP (10 WM) induced a high percentage of cells with partially (quadrant III) or completely
(quadrant IV) depolarized mitochondria (C). Protocatechuic acid was capable of signi¢cantly reducing the number of FCCP-treated cells with
depolarized mitochondria (D). A representative experiment of three is shown here.
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Caco-2 cells appeared to be susceptible to Fas-induced apo-
ptosis. However, albeit the presence of an e⁄cient Fas-medi-
ated pathway, oxLDL-mediated apoptotic cell death did not
involve Fas receptors. In fact, Fas antagonizing antibodies
were ine¡ective in protecting cells from oxLDL-mediated ap-
optosis. This can be of importance if one considers that other
apoptotic stimuli provoking redox alterations such as radia-
tion have been hypothesized to signi¢cantly involve Fas
signaling [16]. Altogether these ¢ndings suggest that oxLDL
induce apoptosis by directly acting on mitochondria. In par-
ticular, the apoptotic proneness of intestinal cells might be
due to a peculiar mitochondrial alteration, i.e. hyperpolariza-
tion, which results in a type II cell death pathway. This also
appears to be supported by the fact that by using ‘baby doses’
of the uncoupler agent FCCP, the inhibition of mitochondria
hyperpolarization exerted by this drug also hindered oxLDL-
induced apoptosis of intestinal cells. These results are in
agreement with recent literature data on the antiapoptotic
activity exerted by low concentrations of uncouplers [33,34].
Moreover, phenolic agents appeared devoid of uncoupler ac-
tivity per se. In fact, when given alone these compounds did
not modify the percentage of cells with reduced v8. By con-
trast, once in the presence of the uncoupler agent (FCCP),
they were not only incapable of ‘additive’ uncoupler activity,
but rather they protected intestinal cell mitochondria from v8
loss induced by FCCP. Altogether, the results herein reported
clearly suggest for the ¢rst time that mitochondrial hyperpo-
larization, previously proposed for lymphoid cells [25], can be
considered a more generalized earlier feature of apoptotic cell
death, and that phenolic agents can e¡ectively modulate in-
testinal cell fate.
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